Centene Corp stock (US15133V1035): Q1 2026 earnings show $3.11 GAAP EPS

Centene Corp released fiscal Q1 2026 results on April 28, reporting GAAP diluted EPS of $3.11. The managed care provider's shares traded around $34 on NYSE as of late October 2025.

Centene Corp, a major US managed care organization, published its fiscal first-quarter 2026 earnings on April 28, 2026, delivering GAAP diluted earnings per share of $3.11, according to Insider Monkey as of May 2026. This release provides key insights into the company's performance amid ongoing healthcare sector dynamics. The stock closed at $34.07 on NYSE on October 24, 2025, down 0.85% that day, per MarketBeat as of 10/24/2025.

As of: 11.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Centene Corp.
• Sector/industry: Healthcare / Managed Care (HMO)
• Headquarters/country: United States
• Core markets: US Medicaid, Medicare, Commercial
• Key revenue drivers: Government-sponsored health programs
• Home exchange/listing venue: NYSE (CNC)
• Trading currency: USD

Centene Corp: core business model

Centene Corp operates as a leading managed healthcare enterprise focused primarily on government-sponsored programs including Medicaid, Medicare, and the Health Insurance Marketplace. The company serves over 28 million medical members across all 50 states as of recent reports. Its business model centers on providing cost-effective health services through a network of providers and administrative efficiencies.

Through subsidiaries, Centene manages health plans tailored to underserved populations, emphasizing value-based care and population health management. This approach has positioned it as one of the largest Medicaid managed care organizations in the US, with significant exposure to state contracts and federal programs relevant to American investors tracking healthcare spending.

Main revenue and product drivers for Centene Corp

Centene's primary revenue stems from premiums earned under government health programs, which accounted for the bulk of its fiscal 2025 topline. In Q1 2026, the company continued this trend with strong adjusted metrics highlighted in its earnings release on April 28, 2026. Key drivers include Medicaid redeterminations, Medicare Advantage growth, and commercial segment expansion.

Additional revenue comes from services like pharmacy benefits management and behavioral health offerings. The company's scale in US markets, particularly in high-growth states, supports stable cash flows amid fluctuating enrollment cycles.

Industry trends and competitive position

The US managed care sector faces pressures from rising medical costs, regulatory changes, and shifting enrollment post-pandemic. Centene competes with peers like Elevance Health (ELV) and Molina Healthcare (MOH), holding a strong position in Medicaid with a diversified portfolio. MarketBeat data as of October 2025 lists it alongside these firms in the MED-HMO industry.

Centene's focus on local market expertise and technology-driven cost controls differentiates it, appealing to US investors interested in defensive healthcare plays with government-backed revenues.

Conclusion

Centene Corp's Q1 2026 earnings reflect ongoing execution in its core managed care operations, with GAAP EPS of $3.11 reported on April 28. Shares have shown volatility, trading at $34.07 on NYSE as of October 24, 2025. Investors monitoring US healthcare trends will watch membership dynamics and medical loss ratios closely. The company's entrenched position in government programs offers visibility into future performance.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.